Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential

Diabetes - United States
doi 10.2337/db10-0630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Antigen Specific Treatment for the Inhibition and Remission of Type 1 Diabetes

Japanese Journal of Clinical Immunology
2008English

Prospects of Antigen-Specific Therapy in Type 1 Diabetes Mellitus

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

A Future for CD3 Antibodies in Immunotherapy of Type 1 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes

Frontiers in Immunology
AllergyImmunology
2018English

New Insights Into Antigen Specific Immunotherapy for Chronic Myeloid Leukemia

Cancer Cell International
Cancer ResearchOncologyGenetics
2012English

Tissue Polypeptide-Specific Antigen Serum Concentrations in Children, Adolescents, and Young Adults With Type 1 Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2002English

A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression

Thyroid
MedicineEndocrinologyMetabolismDiabetes
2014English

New Approaches to the Immunotherapy of Type 1 Diabetes Mellitus Using Interleukin-27

Advanced Pharmaceutical Bulletin
ToxicologyPharmaceuticsPharmacologyPharmaceutical Science
2015English

Efficacy of the Cedar Antigen-Specific Subcutaneous Immunotherapy for Japanese Cedar/Cypress Pollinosis

Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy